Patents by Inventor Anthony Collier

Anthony Collier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC ALKALINE PROTEASE COMPOSITIONS AND USE IN FACILITATING THE TRANSPORT OF AGENTS ACROSS THE GASTROINTESTINAL MUCOSAL LINING
    Publication number: 20090068174
    Abstract: A method of treating an inflammatory condition involving TNF-? in a mammal by administering to a patient a composition with an effective amount of an isolated alkaline protease in an amount effective to inactive TNF-?. The invention also involves compositions, including pharmaceutical compositions containing an isolated alkaline protease in an amount effective to inactive TNF-? especially those from Aspergillus oryzae and/or serve as a transepithial carrier.
    Type: Application
    Filed: September 12, 2007
    Publication date: March 12, 2009
    Applicant: Kansas University Medical Center Research Institute, Inc.
    Inventors: Michael J. Parmely, Rohit Medhekar, Anthony Collier
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTISM
    Publication number: 20080112944
    Abstract: Compositions that may be usefully employed to alleviate symptoms resulting from deficiencies in carbohydrate enzymes, together with methods for the treatment of disorders that are characterized by such deficiencies, such as autism, are provided. The compositions preferably comprise transglucosidase isolated from A. niger.
    Type: Application
    Filed: January 16, 2008
    Publication date: May 15, 2008
    Applicants: KIRKMAN GROUP, INC., NATIONAL ENZYME COMPANY, INC.
    Inventors: Jon PANGBORN, Larry NEWMAN, Rohit MEDHEKAR, Anthony COLLIER, Steven MARR
  • Therapeutic protease compositions
    Publication number: 20080081035
    Abstract: A method of treating an inflammatory condition involving TNF-? in a mammal by administering to a patient a composition with an effective amount of an isolated alkaline protease in an amount effective to inactive TNF-?. The invention also involves compositions, including pharmaceutical compositions containing an isolated alkaline protease in an amount effective to inactive TNF-? especially those from Aspergillus oryzae.
    Type: Application
    Filed: October 3, 2006
    Publication date: April 3, 2008
    Applicant: National Enzyme Company
    Inventors: Michael J. Parmely, Rohit Medhekar, Anthony Collier
  • Compositions and methods for the treatment of autism
    Publication number: 20060115467
    Abstract: Compositions that may be usefully employed to alleviate symptoms resulting from deficiencies in carbohydrate enzymes, together with methods for the treatment of disorders that are characterized by such deficiencies, such as autism, are provided. The compositions preferably comprise transglucosidase isolated from A. niger.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 1, 2006
    Inventors: Jon Pangborn, Larry Newman, Rohit Medhekar, Anthony Collier, Steven Marr